Last edition
News about "Essure Postmarket Surveillance Study FDA"
FDA Posts Interim Results from Required Essure Postmarket Surveillance Study
Although Essure is no longer available for implantation in the U.S., the FDA remains committed to evaluating long-term safety information in women who have received the device, including data from an FDA-required postmarket surveillance study.
Essure Postmarket Surveillance Study FDA | 10/07/2020 | By Darshana | 416
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members